Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, openWorld, idempotent, and non-destructive behavior. The description goes well beyond this by disclosing the fan-out across sources, the meaning of sources_used/sources_failed, that empty sections are real 'no data' rather than bugs, USPTO API sunset soft-fail behavior, and that FDA results are expected to be empty for non-biologic companies.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but exceptionally dense, front-loaded with usage examples and the key 'ALWAYS PREFER' guidance before enumerating outputs. Every clause adds information an agent needs, and the structured listing of return sections makes the complexity navigable without wasted words.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description enumerates every return section (cik, company_name, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used/failed) and explains edge-case semantics. For a two-parameter tool with this breadth, nothing essential is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description adds useful semantic nuance: 'company' and 'ticker' are interchangeable, the value field accepts ticker, zero-padded CIK, or company name, and names resolve via SEC EDGAR's company-name match. This meaningfully enriches the schema rather than merely repeating it.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise verb+resource: it builds a 'full cross-source profile of a US public company' in one parallel call, and gives multiple concrete natural-language triggers. It also distinguishes itself from chained single-source lookups, making it readily separable from sibling tools like resolve_entity or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says to 'ALWAYS PREFER' this tool over chaining single-pack SEC/XBRL/news lookups when the user wants a holistic view, and clarifies acceptable inputs and edge cases like private companies returning resolved:false rather than failing. This gives an agent clear selection guidance and expected fallback behavior.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tool clusters are nearly indistinguishable: ask_pipeworx and ask_pipeworx_beta are explicitly documented as currently identical, scan_competitor_ai_presence is a thin wrapper over ai_visibility_check, and the five polymarket_* tools (edges, edge_tracker, arbitrage, fill_risk, kalshi_spread) share heavily overlapping edge-detection/fill-analysis concerns. entity_profile and recent_changes also both fan out to the same SEC/news/patents sources, so an agent must read full descriptions to avoid misselection.

Naming Consistency3/5

The dominant pattern is imperative verb_first (list_datasets, get_dataset, resolve_entity, validate_claim, scan_dependency, subscribe), but there are notable deviations: noun-phrase names like entity_profile, recent_alerts, recent_changes, bet_research, and deep_research; the ask_pipeworx brand family sits awkwardly beside get_/search_ verbs; and the polymarket_* prefix family forms yet another convention. Names are readable and mostly self-explanatory, but no single consistent scheme is followed.

Tool Count2/5

At 35 tools, this exceeds the 'too many (25+)' threshold, and the bloat is compounded by the server's nominal identity: despite being named 'Bpstat Pt' (Banco de Portugal statistics), only about 5 tools (list_domains, list_datasets, get_dataset, get_series_metadata) actually serve that domain. The other 30 tools span unrelated subsystems — Polymarket betting, npm dependency scanning, AI visibility audits, generic memory, and subscriptions — suggesting several products bundled into one server.

Completeness3/5

For the broader data-gateway interpretation, the lifecycle is well covered: discovery (discover_tools, suggest_questions), query (ask_pipeworx), grounded verification (ask_pipeworx_grounded, validate_claim), deep research (deep_research), profiles/comparisons (entity_profile, compare_entities), monitoring (recent_changes, subscribe/recent_alerts), and memory (remember/recall/forget). However, for the nominal Bpstat statistical domain there is no keyword search over series or datasets — navigation requires knowing domain/dataset ids in advance — and the extreme scatter across unrelated domains leaves each subsystem only partially developed.